Business · 13/03/2003
FDA Releases Guidance on Integration of Dose-Counting Mechanisms into Metered-Dose Inhaler Drug Products
The Food and Drug Administration (FDA) has made available a guidance document to help pharmaceutical manufacturers develop or update metered-dose inhaler (MDI) drug products with accurate dose-counting mechanisms, a requirement for certain inhalation medications.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →